OneMedNet files S-1 for resale of up to 11.68 million shares tied to Yorkville equity line
The Eden Prairie software company registered shares for a $25 million standby equity purchase agreement and insider stock issued to two directors.
OneMedNet Corporation filed a Form S-1 with the Securities and Exchange Commission on July 1, 2026, registering the resale of up to 11,680,535 shares of common stock by selling stockholders. The shares consist of up to 8,500,000 shares issuable under a Standby Equity Purchase Agreement dated July 1, 2026 with YA II PN, Ltd., known as Yorkville, plus 1,885,078 additional shares issued to Dr. Thomas Kosasa and 1,295,457 additional shares issued to Dr. Jeffrey Yu or his affiliate.1
Under the SEPA, the company entered the agreement with Yorkville on July 1, 2026, giving it the option to sell up to $25 million of common stock at its request, with the agreement terminating on its 36-month anniversary.1 Shares sold under advances would be priced at 97% of the market price as defined in the agreement.1 OneMedNet said it will control the timing and amount of any sales, and while Yorkville has no right to require sales, it is obligated to purchase as directed once conditions are met.1
The filing also details a series of insider stock purchases. Dr. Kosasa, a company director, purchased shares in five separate subscription agreements between August 29, 2025 and June 12, 2026, at prices ranging from $0.63 to $0.93 per share, for total gross proceeds of $1.6 million to the company.1 Dr. Yu, an executive officer and director, purchased shares on April 1, 2026 and June 16, 2026 at $0.83 and $0.58 per share, respectively, totaling $850,000 in proceeds.1 Separately, Dr. Yu converted prior cash compensation into 219,429 shares at $0.83 per share under an April 1, 2026 letter agreement.1
OneMedNet's common stock trades on the Nasdaq Capital Market under the symbol "ONMD," with 56,952,652 shares outstanding as of June 30, 2026 and a last closing price of $0.711 per share.1 The company disclosed it received a Nasdaq staff notice on April 14, 2026 for noncompliance with the $1.00 minimum bid price rule, giving it until October 12, 2026 to regain compliance.1 The filing also notes that the company's auditor issued a going concern qualification for fiscal years 2024 and 2025.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.